Introducing ETRAISI: Endovascular Thrombolysis/Thrombectomy Registry in Acute Ischemic Stroke of Iran – A Methodology Protocol
Cerebrovascular Diseases · 10.07.2026 · 1-18
DOI: 10.1159/000553448 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Cerebrovascular Diseases, online erschienen am 10.07.2026. Verfasst von Mojdeh Ghabaee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran, mojdeh.ghabaee@gmail.com. Die Arbeit nennt 19 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Stroke is a leading cause of mortality and long-term disability worldwide and also has a substantial burden in Iran. Acute ischemic stroke (AIS) accounts for most cases, and patients’ outcomes are highly affected by timely acute care and reperfusion therapies. However, national data on stroke care processes and outcomes remain fragmented. Thus, establishing a standardized stroke registry is essential to monitor real-world practice, evaluate quality metrics, and support research and healthcare policies.
Methods
ETRAISI (Endovascular Thrombolysis/Thrombectomy Registry in Acute Ischemic Stroke of Iran) is a prospective, quality-of-care, hospital-based registry designed to provide a sustainable data infrastructure for adult AIS patients eligible for intravenous thrombolysis (within 4.5 h of onset)/mechanical thrombectomy (within 6 h of onset). Standardized data across six domains, including demographics, clinical characteristics, stroke characteristics and workup results, time metrics, treatments, and outcomes, are collected from admission through discharge and 3-month follow-up using a secure web-based platform. Data quality is ensured through predefined validation rules, audits, and centralized oversight, with ethical approval and informed consent obtained for all participants.
Conclusion
By systematically recording detailed workflow processes, treatment, and follow-up outcomes, ETRAISI addresses gaps in stroke data and enables quality improvement, research, and evidence-based policy-making in a resource-limited setting. The registry provides a scalable national framework for optimizing stroke care and strengthening stroke surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran, mojdeh.ghabaee@gmail.com.
- Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Occupational Sleep Research Center, Baharloo Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- University Research and Development Center, Tehran University of Medical Sciences, Tehran, Iran.
- Khajeh Nasir Toosi University of Technology, Tehran, Iran.
Zitieren
APA
Ghabaee, M., Sarvestani, Z., Eskandarieh, S., Amirifard, H., Moshayedi, P., Hajrezaei, Z., Rashidi, F., Jameie, M., Esmailzadeh, H., Niknam, M., Nahvijou, A., & Azizan, Z. (2026). Introducing ETRAISI: Endovascular Thrombolysis/Thrombectomy Registry in Acute Ischemic Stroke of Iran – A Methodology Protocol. Cerebrovascular Diseases, 1-18. https://doi.org/10.1159/000553448
Vancouver
Ghabaee M, Sarvestani Z, Eskandarieh S, Amirifard H, Moshayedi P, Hajrezaei Z, et al. Introducing ETRAISI: Endovascular Thrombolysis/Thrombectomy Registry in Acute Ischemic Stroke of Iran – A Methodology Protocol. Cerebrovascular Diseases. 2026:1-18. doi:10.1159/000553448
BibTeX
@article{Ghabaee2026,
author = {Ghabaee, Mojdeh and Sarvestani, Zahra and Eskandarieh, Sharareh and Amirifard, Hamed and Moshayedi, Pouria and Hajrezaei, Zahra and Rashidi, Farhang and Jameie, Melika and Esmailzadeh, Hamid and Niknam, Mahnaz and Nahvijou, Azin and Azizan, Zahra},
title = {Introducing ETRAISI: Endovascular Thrombolysis/Thrombectomy Registry in Acute Ischemic Stroke of Iran – A Methodology Protocol},
journal = {Cerebrovascular Diseases},
year = {2026},
pages = {1--18},
doi = {10.1159/000553448}
}
EUVIMED